Peter H. Norgaard

Hvidovre, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 54 publications

Localized blastic plasmacytoid dendritic cell neoplasm associated with progressive clonal hematopoiesis and myelodysplastic syndrome.

Localized blastic plasmacytoid dendritic cell neoplasm associated with progressive clonal hematopoiesis and myelodysplastic syndrome.

Journal: APMIS : acta pathologica, microbiologica, et immunologica Scandinavica

Published: September 27, 2024

TP53 Mutation Is the Only Robust Mutational Biomarker for Outcome Found in a Consecutive Clinical Cohort of Real-Word Patients With Primary Large B-Cell Lymphoma.

TP53 Mutation Is the Only Robust Mutational Biomarker for Outcome Found in a Consecutive Clinical Cohort of Real-Word Patients With Primary Large B-Cell Lymphoma.

Journal: European journal of haematology

Published: September 18, 2024

Mutational heterogeneity in large B-cell lymphoma: insights from paired biopsies.

Mutational heterogeneity in large B-cell lymphoma: insights from paired biopsies.

Journal: Annals of hematology

Published: July 07, 2024

Localized large B-cell lymphoma with MYC and BCL6 rearrangements as an unexpected finding in an appendectomy specimen.

Localized large B-cell lymphoma with MYC and BCL6 rearrangements as an unexpected finding in an appendectomy specimen.

Journal: APMIS : acta pathologica, microbiologica, et immunologica Scandinavica

Published: March 22, 2024

Mutational landscape in Waldenström macroglobulinemia evaluated using a next-generation sequencing lymphoma panel in routine clinical practice.

Mutational landscape in Waldenström macroglobulinemia evaluated using a next-generation sequencing lymphoma panel in routine clinical practice.

Journal: Leukemia & lymphoma

Published: February 10, 2024

Co-shared genomic alterations within tumors from patients with both myeloproliferative neoplasms and lymphoma.

Co-shared genomic alterations within tumors from patients with both myeloproliferative neoplasms and lymphoma.

Journal: Haematologica

Published: June 21, 2023

Multi-site pre-therapeutic biopsies demonstrate genetic heterogeneity in patients with newly diagnosed diffuse large B-cell lymphoma.

Multi-site pre-therapeutic biopsies demonstrate genetic heterogeneity in patients with newly diagnosed diffuse large B-cell lymphoma.

Journal: Leukemia & lymphoma

Published: June 17, 2023

Next generation sequencing in routine diagnostics of mature non-Hodgkin's B-cell lymphomas.

Next generation sequencing in routine diagnostics of mature non-Hodgkin's B-cell lymphomas.

Journal: European journal of haematology

Published: April 21, 2023

Bone Involvement as a Primary Rare Manifestation of Waldenstrom Macroglobulinemia: A Case Report and Prevalence in a Nationwide Population-Based Cohort Study.

Bone Involvement as a Primary Rare Manifestation of Waldenstrom Macroglobulinemia: A Case Report and Prevalence in a Nationwide Population-Based Cohort Study.

Journal: Journal of hematology

Published: October 31, 2022

Inactivating BTK mutations in large B-cell lymphoma in a real-world cohort: Strong correlation with BCL2 translocation.

Inactivating BTK mutations in large B-cell lymphoma in a real-world cohort: Strong correlation with BCL2 translocation.

Journal: EJHaem

Published: April 29, 2022

Inhibitors of ERp44, PDIA1, and AGR2 induce disulfide-mediated oligomerization of Death Receptors 4 and 5 and cancer cell death.

Inhibitors of ERp44, PDIA1, and AGR2 induce disulfide-mediated oligomerization of Death Receptors 4 and 5 and cancer cell death.

Journal: Cancer letters

Published: December 10, 2021

The value of next-generation sequencing in routine diagnostics and management of patients with cytopenia.

The value of next-generation sequencing in routine diagnostics and management of patients with cytopenia.

Journal: International journal of laboratory hematology

Published: October 29, 2021

Showing 1-12 of 54

Last Updated: 09/26/2026